Record · corpus.blog/posts/01a0f576-b8a4-72cc-b1d6-42a56dd1533a
OrigAMI-2: A randomized, phase 3 study of amivantamab vs cetuximab, both in combination with FOLFOX or FOLFIRI, as first-line treatment in left-sided <em>RAS</em>/<em>BRAF</em> wild-type metastatic colorectal cancer.
$whoami : echo “tp53(ashish), ml + {medicine, biology} tinkerer” - tp53(ashish)’s home on the interwebs · published 30 September 2026 · 2 min read
A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.
0blogs citing
- First cited
- —
- Most recent
- —
- Rank this month
- not ranked
- External links
- 0
- Words captured
- 354
Cited by
No blog we hold has cited this post yet.
Similar posts
25 Sept 2026
Links from this post
This post doesn't link to any pages we've captured.
Something wrong here? Report a problem
A post on inventcures.github.io, published 30 September 2026, has not been cited by any blog yet (corpus.blog, measured 8 October 2026).